Adage Capital Partners
FBIO icon

Adage Capital Partners’s Fortress Biotech FBIO Stock Holding History

Adage Capital Partners’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,333
Closed -$89K – 727
2019
Q1 		$89K Hold
3,333
– – ﹤0.01% 685
2018
Q4 		$43K Hold
3,333
– – ﹤0.01% 703
2018
Q3 		$80K Hold
3,333
– – ﹤0.01% 707
2018
Q2 		$149K Buy
3,333
+2,226
+201% +$125K ﹤0.01% 727
2018
Q1 		$76K Buy
+1,107
New +$70.1K ﹤0.01% 715

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Adage Capital Partners's FBIO Position: Q2 2019 in Review

Adage Capital Partners sold out of Fortress Biotech (FBIO) in Q2 2019, closing a stake of 3,333 shares — an estimated $89K sold.

Adage Capital Partners first reported a position in FBIO in Q1 2018 and held it in 5 quarters. The position peaked at $149K in Q2 2018. 49 funds tracked by Wall St. Rank hold FBIO as of Q2 2019.

  • Adage Capital Partners reported no remaining Fortress Biotech position as of Q2 2019 after selling out during the quarter.
  • Adage Capital Partners sold 3,333 Fortress Biotech shares in Q2 2019, an estimated $89K.
  • Adage Capital Partners first reported a position in Fortress Biotech in Q1 2018 and held it in 5 quarters.
  • Adage Capital Partners's Fortress Biotech position peaked at $149K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2019.

Based on Adage Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.